----- Original Message ----- From: "Williams, Susan" <[log in to unmask]> To: "AMSA International Health" <[log in to unmask]> Sent: Monday, November 18, 2002 9:37 AM Subject: [intlhealth] Human Trial of Global HIV Vaccine Launched > > > First Human Trial of 'Global' HIV Vaccine Launched > > 14 November 2002 > By Alan Mozes > > American researchers have reached what they hope is a milestone in AIDS > research, with the launch of the first human trial of a single AIDS > vaccine designed to simultaneously prevent infection with the three most > common forms of HIV. > > The first trial phase of the so-called "global vaccine" was launched > yesterday [13 November] by the National Institutes of Health (NIH) in > Bethesda, Maryland, under the supervision of the Vaccine Research Center > (VRC). > > The trial vaccine incorporates modified parts of four different HIV > genes. The genes are drawn from HIV subtype B--the most prevalent form > of HIV in North America and Western Europe--as well as from subtypes A > and C, which are the most common types in Africa and Asia. > > Copyright Reuters 2002 > > For the Full Article, go to: > http://reuters.com/news_article.jhtml?type=healthnews&StoryID=1742607# > > Vaccine Research Center > http://www.niaid.nih.gov/vrc/ > > > > > This e-mail and any files transmitted with it may contain information that > is PRIVILEGED, CONFIDENTIAL, and exempt from disclosure under applicable > law. It is intended only for the individual(s) or entity named above. If > you are not an intended recipient of this e-mail, you are hereby notified > that any unauthorized use, dissemination or copying of this e-mail or the > information contained in it or attached to it is strictly prohibited. If > you have received this e-mail in error, please delete it and immediately > notify the person named above by reply e-mail. Thank you. > > > > --- > You are currently subscribed to intlhealth as: [log in to unmask] > To unsubscribe send a blank email to [log in to unmask] >